Patients Rising Now
  • Home
  • About
    • About Us
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Position Statements
    • Policy Supported
  • Get Involved
    • Advocacy Master Class
    • Take Action
    • State by State Actions
    • Virtual Advocacy Chat
    • Events
    • Advocacy Toolkit
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Position Statements
    • Policy Supported
  • Get Involved
    • Advocacy Master Class
    • Take Action
    • State by State Actions
    • Virtual Advocacy Chat
    • Events
    • Advocacy Toolkit
  • Donate

A dangerous plan for rationing essential prescription drugs

Aug 6, 2019 | ICER, News, QALY

The midterms are over and it’s time to get back to discussing issues that impact Americans on a daily basis. Things like health care and, specifically how to reduce costs. President Trump has made lowering the cost of prescription drugs one of his priorities. It seems...
Read more

HHS Secretary Alex Azar doesn’t want drug access to become an equation

Apr 19, 2019 | News, QALY

On April 8, at a Harvard Medical School forum hosted by Pioneer Institute, President Trump’s secretary of health and human services was asked whether it was advisable for state Medicaid programs to use “cost-effectiveness reviews” that have become common in Europe....
Read more

Categories

  • Access
  • Actions
  • Connecticut
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Press Releases
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Terry's Hot Take
  • Uncategorized
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

340B Access to Care Advocacy Biden Administration Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Importation Drug Manufacturing Drug Pricing drug rebate Elizabeth Warren fail first FDA H.R.3 Healthcare Inequities Health Insurance hospital bills HR 3708 hsa ICER Imported Drugs Insurance design Joe Biden Lupus medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs Patient Access Patients Assitance PBM pharmacy benefit managers Preexisting Conditions Price Transparency Prior Authorization QALY Step Therapy transparency Value Framework

Recent Posts

  • Support the Supplemental Security Income Restoration Act
  • FDA Must Step Up Oversight of Hand Sanitizer Safety
  • S2 | E28: Take Control of Your Health Data
  • What We Need to Know About Standing Orders in Health Care
  • Cigna’s Letters to Patients and Providers on Cosentyx

Sign up for updates


Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now